Chemerin is closely associated with obesity, inflammation, and vascular dysfunction, acting as a key regulator of glucose and lipid metabolism through the modulation of insulin sensitivity, lipolysis, and adipocyte differentiation (45, 46). Here, RARRES2 is linked to obesity disorder.